Ignite Creation Date:
2024-05-06 @ 4:00 PM
Last Modification Date:
2024-10-26 @ 2:01 PM
Study NCT ID:
NCT04831073
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-03-01
First Post:
2021-03-29
Brief Title:
European Registry of Type A Aortic Dissection
Sponsor:
Helsinki University Central Hospital
Organization:
Helsinki University Central Hospital
Study Overview
Official Title:
European Registry of Type A Aortic Dissection
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2023-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ERTAAD
Brief Summary:
Acute Stanford type A aortic dissection TAAD is a life-threatening condition Surgery is usually performed as a salvage procedure and is associated with significant postoperative early mortality and morbidity Understanding the patients conditions and treatment strategies which are associated with these adverse events is essential for an appropriate management of acute TAAD
Detailed Description:
Twenty centers from eight European centers of cardiac surgery have collaborated to create a multicentre observational registry ERTAAD which will enroll consecutive patients who underwent surgery for acute TAAD from January 2005 to March 2021 The investigators will compare patients comorbidities condition at referral surgical strategies and perioperative treatments in patients with and without early and late adverse events The primary clinical outcome will be in-hospital mortality late mortality and reoperations on the aorta Secondary outcomes will be stroke acute kidney injury surgical site infection reoperation for bleeding transfusion of blood products and length of stay in the intensive care unit
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None